Introduction
Spinal and bulbar muscular atrophy (SBMA, Kennedy's disease) is an X-linked, adult-onset disease with slowly progressive weakness of the bulbar and extremity muscles due to degeneration of motor neurons in the brainstem and spinal cord. Affected males may show signs of androgen insensitivity, such as breast enlargement and reduced fertility. The causative mutation is a CAG repeat expansion in the androgen receptor gene that leads to an expanded polyglutamine tract in the N-terminal domain of the receptor protein (La Spada et al., 1991) . SBMA is thus one of about 30 diseases known to be caused by repeat expansion and one of at least nine that are caused by expanded polyglutamine tracts. This review summarizes what has been learned since the disease gene discovery about the pathophysiology of SBMA and the prospects for treatment. Other reviews have recently appeared elsewhere (Parodi and Pennuto, 2011; Banno et al., 2012) The androgen receptor is a nuclear receptor, and the N-terminal domain is in a part of the protein separate from the hormone and DNA binding domains, a part of the protein that is involved in interaction with other nuclear proteins. Thus the mutant receptor has normal ligand biding, and in the presence of ligand it dissociates from cytoplasmic heat shock proteins and is normally taken up into the nucleus, but target gene activation is altered due to aberrant binding to other nuclear factors. This causes some loss of normal receptor function, as evidenced by functional studies and by the signs of androgen insensitivity that occur in patients with
